Chris astle zymeworks
WebApr 12, 2024 · Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. About the company Rewards Price-To-Earnings ratio (4.8x) is below the US market (14.8x) Became profitable this year Risk Analysis WebMar 8, 2024 · Christopher Astle; Senior VP & CFO; Zymeworks Inc. Jack W. Spinks; Manager of IR; Zymeworks Inc. Unidentified Company Representative Andrew Scott Berens; Senior MD of Medical Supplies and...
Chris astle zymeworks
Did you know?
WebZymeworks Inc. 19,162 followers 1y We are thrilled to announce the promotion of Dr. Chris Astle to Senior Vice President and Chief Financial Officer! Chris brings a wealth of … WebDec 31, 2024 · Zymeworks Inc. (Nasdaq: ZYME) is a global biotechnology company committed to the discovery, development, and commercialization of novel, multifunctional …
WebMar 7, 2024 · VANCOUVER, British Columbia, March 07, 2024--Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel multifunctional biotherapeutics, today reported financial... WebMar 7, 2024 · Financial quotes, charts and historical data for stocks, mutual funds and major indices, including My Portfolio, a personal stock tracker.
WebFeb 26, 2024 · Chris Astle Chief Financial Officer at Zymeworks Published Feb 26, 2024 + Follow Published by Chris Astle Resident CFO in the Finance Director Magazine - February 19, 2024. Co-authored... WebMar 1, 2013 · View Chris Astle, P.Eng, PMP’S profile on LinkedIn, the world’s largest professional community. Chris has 8 jobs listed on their profile. See the complete profile …
WebDr. Astle joined Zymeworks in April 2024 and currently serves as Senior Vice President and Chief Financial Officer. Prior to joining Zymeworks, Dr. Astle worked as a Chief Financial …
WebAug 4, 2024 · "We continue to make steady progress towards reducing future operating costs and strengthening our balance sheet," said Chris Astle, Ph.D., SVP and Chief Financial Officer. "With the restructuring ... ccbcc skillsoftWebNov 14, 2024 · Chris Astle Chief Financial Officer at Zymeworks View articles by Chris Astle The CFO as strategist: from SMEs to… October 8, 2024 32 likes1 comment The … cc bcc reply-toWebAbout. Dr. Astle joined Zymeworks in April 2024 and currently serves as Senior Vice President and Chief Financial Officer. Prior to joining Zymeworks, Dr. Astle worked as a Chief Financial Officer at the CFO Centre in British Columbia, Canada from March 2024 to March 2024, and as Vice President, Finance at Alder BioPharmaceuticals Inc. in Seattle, … bussineses in owings milllsWebFeb 24, 2024 · Chris joined the finance group at Zymeworks in 2024 after relocating from Seattle where he previously served as Vice President at Alder Pharmaceuticals (sold to Lundbeck in 2024 for $1.6... bussineshostesWebFeb 24, 2024 · Chris joined the finance group at Zymeworks in 2024 after relocating from Seattle where he previously served as Vice President at Alder Pharmaceuticals (sold to … bussines credit cards fair build creditWebMay 4, 2024 · Zymeworks is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Zymeworks’ suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of highly differentiated product candidates. bussinesforhome top earners 2020WebJan 22, 2024 · Chris Astle Chief Financial Officer at Zymeworks Published Jan 22, 2024 + Follow Published by Chris Astle Resident CFO in the Finance Director Magazine - January 15, 2024 ccbcc training